Stablepharma

Patient receiving vaccine
#Immunology / Virology & Vaccines #National Institute for Health Research #Phase I trial #Stablepharma #Vaccines

Fridge-free vaccine effective at 30°C for at least two years

The world-first trial of a fridge-free tetanus-diphtheria vaccine has produced encouraging results that could improve access worldwide to crucial treatments.   Around half of vaccines are wasted globally each year, according to the World Health Organization, because of temperature changes during storage and transport.  Fridge-free vaccines… Read More

#News #Trending News